The Valley Desk

NCT00066196 · Interventional trial

Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

Overall registry status Completed

Phase 2

Conditions Malignant Metastatic Melanoma, Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov